Distinct recognition of complement iC3b by integrins αβ and αβ.

Proc Natl Acad Sci U S A

Program in Cellular and Molecular Medicine, Boston Children's Hospital and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115;

Published: March 2017

Recognition by the leukocyte integrins αβ and αβ of complement iC3b-opsonized targets is essential for effector functions including phagocytosis. The integrin-binding sites on iC3b remain incompletely characterized. Here, we describe negative-stain electron microscopy and biochemical studies of αβ and αβ in complex with iC3b. Despite high homology, the two integrins bind iC3b at multiple distinct sites. αβ uses the α αI domain to bind iC3b on its C3c moiety at one of two sites: a major site at the interface between macroglobulin (MG) 3 and MG4 domains, and a less frequently used site near the C345C domain. In contrast, αβ uses its αI domain to bind iC3b at the thioester domain and simultaneously interacts through a region near the α β-propeller and β βI domain with a region of the C3c moiety near the C345C domain. Remarkably, there is no overlap between the primary binding site of αβ and the binding site of αβ on iC3b. Distinctive binding sites on iC3b by integrins αβ and αβ may be biologically beneficial for leukocytes to more efficiently capture opsonized pathogens and to avoid subversion by pathogen factors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380021PMC
http://dx.doi.org/10.1073/pnas.1620881114DOI Listing

Publication Analysis

Top Keywords

αβ αβ
16
αβ
12
integrins αβ
12
bind ic3b
12
ic3b
8
ic3b integrins
8
sites ic3b
8
αβ αi
8
αi domain
8
domain bind
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!